Fundraising FoxEntegrion
Durham, US · Delaware corporation · 1 known investors
Find your way into Entegrion
Sign up to see every warm intro you have to Entegrion
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Entegrion team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Entegrion develops a point-of-care viscoelastic coagulation monitoring system (VCM) for rapid hemostasis assessment in clinical settings including trauma, surgery, and obstetrics. The company serves clinicians in civilian and military medicine, with regulatory clearance in Europe.
Founders & leadership
Investors · 1
How we know: Hatteras Venture Partners's portfolio page · the VCSheet dataset · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$20.5M disclosed across 2 rounds · 2015–2022
▶$13.9MraisedJul 2022 · 87 investors · BiotechnologyRule 506(b)
- Robert CappsDirector
- Pierre NoelDirector
- Ronald SacherDirector
- Brian GiblerDirector
- Albert ValadaExecutive Officer, Director, Promoter
- Christopher RumanaDirector
- Patrick NashDirector
- Thomas EdwardsDirector
- Richard MartinExecutive Officer, Promoter
- J. True MartinDirector
- Offering amount
- $20M
- Amount sold
- $13.9M
- First sale
- Jun 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6.7MraisedMay 2019 · 73 investors · BiotechnologyRule 506(b)
- Richard MartinExecutive Officer
- Susan ReyerExecutive Officer
- Michael GaligerExecutive Officer
- John MowellDirector
- Thomas EdwardsDirector
- Christopher RumanaDirector
- Patrick NashDirector
- W Brian GiblerDirector
- Pierre NoelDirector
- Robert CappsDirector
- J True MartinDirector
- Richard SacherDirector
- Offering amount
- $8M
- Amount sold
- $6.7M
- First sale
- Oct 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 1
Companies working in the same space as Entegrion.
In the news
Frequently asked questions
- What does Entegrion do?
- Entegrion develops a point-of-care viscoelastic coagulation monitoring system (VCM) for rapid hemostasis assessment in clinical settings including trauma, surgery, and obstetrics. The company serves clinicians in civilian and military medicine, with regulatory clearance in Europe.
- Who are Entegrion's investors?
- Entegrion's investors include Hatteras Venture Partners.
- How much funding has Entegrion raised?
- Entegrion has disclosed $20.5M raised across 2 rounds.
- Where is Entegrion headquartered?
- Entegrion is headquartered in Durham, US.